Projects per year
Fingerprint Dive into the research topics where Thomas Matthew Habermann is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 27 Similar Profiles
Lymphoma, Large B-Cell, Diffuse
Medicine & Life Sciences
Non-Hodgkin's Lymphoma
Medicine & Life Sciences
Lymphoma
Medicine & Life Sciences
Survival
Medicine & Life Sciences
Follicular Lymphoma
Medicine & Life Sciences
Disease-Free Survival
Medicine & Life Sciences
B-Cell Lymphoma
Medicine & Life Sciences
Hodgkin Disease
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 1978 2017
- 2 Finished
Lymphoma Specialized Program of Research Excellence
Macon, W. R., Dogan, A. M., Ansell, S. M., Gupta, M. D., Witzig, T. E., Cerhan, J. R., Habermann, T. M., Ratliff, T. L., Link, B. K., Ratliff, T. L., Juweid, M., Ballas, Z., Link, B. K., Ratliff, T., Geyer, S. M., Weiner, G., Lentz, S., Hohl, R., Smith, B. J., Kaufmann, S. H., Feldman, A. L. & Witzig, T. E.
9/11/02 → 6/30/17
Project: Research project
Lymphoma
Non-Hodgkin's Lymphoma
Molecular Epidemiology
B-Lymphocytes
B-Cell Lymphoma
EASTERN COOPERATIVE ONCOLOGY GROUP
Habermann, T. M., Hahn, R. & Edmonson, J.
6/1/78 → 4/30/16
Project: Research project
Antineoplastic Protocols
Organized Financing
Neoplasms
Research
Clinical Protocols
Research Output 1983 2019
Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma
Wang, Y., Wenzl, K., Manske, M. K., Asmann, Y., Sarangi, V., Greipp, P. T., Krull, J. E., Hartert, K., He, R., Feldman, A. L., Maurer, M. J., Slager, S. L., Nowakowski, G. S., Habermann, T. M., Witzig, T. E., Link, B. K., Ansell, S. M., Cerhan, J. R. & Novak, A. J., Sep 1 2019, In : Blood cancer journal. 9, 9, 73.Research output: Contribution to journal › Article
Open Access
Lymphoma, Large B-Cell, Diffuse
B-Cell Lymphoma
Immunotherapy
Lymphoma
Hodgkin Disease
6
Citations
(Scopus)
Cause of death in follicular lymphoma in the first decade of the rituximab era: A pooled analysis of French and US cohorts
Sarkozy, C., Maurer, M. J., Link, B. K., Ghesquieres, H., Nicolas, E., Thompson, C. A., Traverse-Glehen, A., Feldman, A. L., Allmer, C., Slager, S. L., Ansell, S. M., Habermann, T. M., Bachy, E., Cerhan, J. R. & Salles, G., Jan 10 2019, In : Journal of Clinical Oncology. 37, 2, p. 144-152 9 p.Research output: Contribution to journal › Article
Follicular Lymphoma
Cause of Death
Lymphoma
Disease-Free Survival
Rituximab
Detection of extranodal and spleen involvement by FDG-PET imaging predicts adverse survival in untreated follicular lymphoma
St-Pierre, F., Broski, S., LaPlant, B. R., Ristow, K., Maurer, M. J., Macon, W. R., Habermann, T. M., Ansell, S. M., Thompson, C. A., Micallef, I., Nowakowski, G. S. & Witzig, T. E., Jan 1 2019, In : American journal of hematology.Research output: Contribution to journal › Article
Follicular Lymphoma
Spleen
Bone and Bones
Survival
Disease-Free Survival
Host genetic variation in tumor necrosis factor and nuclear factor-κB pathways and overall survival in mantle cell lymphoma: A discovery and replication study
Wang, Y., Habermann, T. M., Wang, S. S., Maurer, M. J., Sarangi, V., Link, B. K., Feldman, A. L., Inwards, D. J., Witzig, T. E., Cozen, W., Rothman, N., Asmann, Y., Slager, S. L. & Cerhan, J. R., Jan 1 2019, In : American journal of hematology.Research output: Contribution to journal › Letter
Open Access
Mantle-Cell Lymphoma
Tumor Necrosis Factor-alpha
Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes
Abeykoon, J. P., Zanwar, S., Ansell, S. M., Gertz, M., Kumar, S. K., Manske, M., Novak, A. J., King, R., Greipp, P. T., Go, R., Inwards, D., Muchtar, E., Habermann, T. M., Witzig, T. E., Thompson, C. A., Dingli, D. M., Lacy, M., Leung, N., Dispenzieri, A., Gonsalves, W. & 5 others, , Jan 1 2019, (Accepted/In press) In : British journal of haematology.Research output: Contribution to journal › Article
Waldenstrom Macroglobulinemia
Clinical Trials
Confidence Intervals
Disease-Free Survival
Immunoglobulin M